Marrone Bio Innovations (MBII) Stock Analysis

What Marrone Bio Innovations does

Marrone Bio Innovations, Inc. (MBII) specializes in the creation, development, and commercialization of biologically-derived products for use in agriculture. The company's product line is strategically designed to bolster crop protection, improve overall plant vitality, and provide essential nutrition for various crops. Their extensive portfolio includes solutions such as Emergen, Foramin (and its ST variant), Optima, Takla, Pacesetter, Ympact, and UBP (and its ST variant), all engineered to enhance crop health, maximize yields, and improve the final quality of produce. For pest control, MBII offers Grandevo, a bioinsecticide that targets sucking and chewing insects, and Venerate, another bioinsecticide effective against a range of chewing and sucking insects, as well as mites. To combat environmental stressors, Haven is available as a plant health product formulated to reduce sun-induced stress and combat dehydration. Furthermore, their Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers play a crucial role in preventing, managing, and eliminating algal, fungal, and bacterial diseases throughout both the agricultural and horticultural sectors. The company also supplies bionematicides like Majestene, which controls soil-dwelling nematodes and certain soil-borne insects, and Zelto, specifically formulated to protect turf areas, including golf course fairways and greens, by promoting robust plant and root health. Rounding out their offerings are Regalia and Stargus, products that deliver defense against fungal and bacterial diseases while concurrently boosting crop yields and quality. Marrone Bio Innovations distributes its offerings through a blended approach, employing a direct sales force in addition to working with distributors and various commercial partners. The company, initially incorporated in 2006 under the name Marrone Organic Innovations, Inc., is headquartered in Raleigh, North Carolina.

Key metrics

ETFs linked to MBII

Broad-market and Basic Materials sector ETFs an investor holding Marrone Bio Innovations is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MBII fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Marrone Bio Innovations?

Marrone Bio Innovations trades under the ticker MBII on NASDAQ.

Which exchange is MBII listed on?

MBII is listed on NASDAQ.

What sector does Marrone Bio Innovations operate in?

Marrone Bio Innovations is classified in the Basic Materials sector (Agricultural Inputs industry).

How can PortView help analyze MBII in a portfolio?

PortView shows MBII's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.